160 related articles for article (PubMed ID: 38805342)
21. Amisulpride versus amineptine and placebo for the treatment of dysthymia.
Boyer P; Lecrubier Y; Stalla-Bourdillon A; Fleurot O
Neuropsychobiology; 1999; 39(1):25-32. PubMed ID: 9892856
[TBL] [Abstract][Full Text] [Related]
22. An update on the pharmacotherapeutic strategies for the treatment of dysthymic disorder: a systematic review.
Quagliato LA; Primavera D; Fornaro M; Preti A; Carta MG; Nardi AE
Expert Opin Pharmacother; 2023; 24(18):2035-2040. PubMed ID: 37787056
[TBL] [Abstract][Full Text] [Related]
23. A comparative trial of psychotherapy and pharmacotherapy for "pure" dysthymic patients.
Markowitz JC; Kocsis JH; Bleiberg KL; Christos PJ; Sacks M
J Affect Disord; 2005 Dec; 89(1-3):167-75. PubMed ID: 16263177
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta-analysis.
Zangani C; Giordano B; Stein HC; Bonora S; D'Agostino A; Ostinelli EG
Hum Psychopharmacol; 2021 Nov; 36(6):e2801. PubMed ID: 34727399
[TBL] [Abstract][Full Text] [Related]
25. Prescribing patterns of psychotropic medications and clinical features in patients with major depressive disorder with and without comorbid dysthymia in China.
Feng Y; Sha S; Hu C; Wang G; Ungvari GS; Chiu HF; Ng CH; Si TM; Chen DF; Fang YR; Lu Z; Yang HC; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Xiang YT
Asia Pac Psychiatry; 2017 Mar; 9(1):. PubMed ID: 27759189
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of drug treatments for dysthymia: a systematic review and meta-analysis.
de Lima MS; Hotoph M; Wessely S
Psychol Med; 1999 Nov; 29(6):1273-89. PubMed ID: 10616934
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and treatment of dysthymia in children and adolescents.
Nobile M; Cataldo GM; Marino C; Molteni M
CNS Drugs; 2003; 17(13):927-46. PubMed ID: 14533944
[TBL] [Abstract][Full Text] [Related]
28. [Dysthymia: a chronic illness and its treatment].
Aschauer HN
Wien Med Wochenschr; 1999; 149(18):503-10. PubMed ID: 10637954
[TBL] [Abstract][Full Text] [Related]
29. Psychotherapy for chronic major depression and dysthymia: a meta-analysis.
Cuijpers P; van Straten A; Schuurmans J; van Oppen P; Hollon SD; Andersson G
Clin Psychol Rev; 2010 Feb; 30(1):51-62. PubMed ID: 19781837
[TBL] [Abstract][Full Text] [Related]
30. Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study.
Amore M; Jori MC;
Int Clin Psychopharmacol; 2001 Nov; 16(6):317-24. PubMed ID: 11712619
[TBL] [Abstract][Full Text] [Related]
31. Recognition and treatment of dysthymia in elderly patients.
Bellino S; Bogetto F; Vaschetto P; Ziero S; Ravizza L
Drugs Aging; 2000 Feb; 16(2):107-21. PubMed ID: 10755327
[TBL] [Abstract][Full Text] [Related]
32. Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis.
Cuijpers P; Dekker J; Hollon SD; Andersson G
J Clin Psychiatry; 2009 Sep; 70(9):1219-29. PubMed ID: 19818243
[TBL] [Abstract][Full Text] [Related]
33. Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence.
De Lima MS; Hotopf M
Drug Saf; 2003; 26(1):55-64. PubMed ID: 12495364
[TBL] [Abstract][Full Text] [Related]
34. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs.
Browne G; Steiner M; Roberts J; Gafni A; Byrne C; Dunn E; Bell B; Mills M; Chalklin L; Wallik D; Kraemer J
J Affect Disord; 2002 Apr; 68(2-3):317-30. PubMed ID: 12063159
[TBL] [Abstract][Full Text] [Related]
35. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011006. PubMed ID: 29683474
[TBL] [Abstract][Full Text] [Related]
36. Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies.
Cuijpers P; van Straten A; van Oppen P; Andersson G
J Clin Psychiatry; 2008 Nov; 69(11):1675-85; quiz 1839-41. PubMed ID: 18945396
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of psychotherapy and combination treatment for chronic depression.
Arnow BA; Constantino MJ
J Clin Psychol; 2003 Aug; 59(8):893-905. PubMed ID: 12858430
[TBL] [Abstract][Full Text] [Related]
38. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
[TBL] [Abstract][Full Text] [Related]
39. A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes.
Rocca P; Marchiaro L; Rasetti R; Rivoira E; Bogetto F
Psychiatry Res; 2002 Oct; 112(2):145-52. PubMed ID: 12429360
[TBL] [Abstract][Full Text] [Related]
40. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
Ravindran AV; Guelfi JD; Lane RM; Cassano GB
J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
